Orphan drugs have important societal value as they improve patient quality of life and address unmet...
Read moreFaster access to new treatments for very rare conditions announced following a revised decision maki...
Read moreIntroduction of a new German Act - Strengthening Pharmaceutical Supply in the Statutory Health Insur...
Read moreThe German Ministry of Health has recently published its final bill concerning pricing and market ac...
Read moreThe methodology to be used within the cost-effectiveness HTA evaluations is likely to be based on a ...
Read morePharmaceutical companies are able to charge significantly higher prices as these products are addres...
Read moreRemap Consulting presents NICE's highly specialised technology methodology to EUCOPE
Read moreUpdates on the latest news on NICE's Value Based Assessment, as well as the approval of ultra-orphan...
Read more